Long-term effects of Covid-19 disease are still poorly understood. However, similarities between the responses to SARS-CoV-2 and certain nanomaterials suggest fibrotic pulmonary disease as a concern for public health in the next future. Cross-talk between nanotoxicology and other relevant disciplines can help us to deploy more effective Covid-19 therapies and management strategies.
Keywords: COVID-19; Coronavirus; Fibrosis; Nanotoxicology; Sars-Cov-2; Virus-host interaction.
© 2020 The Author(s).